Prof. Dennis Black, Professor – Department of Epidemiology and Biostatistics, University of California at San Francisco (USA)
[youtube url=”http://www.youtube.com/watch?v=tmxnL39WQUI” width=”500″ height=”300″]
Sospensione del denosumab: quando e come utilizzare lo zoledronato?
Commento dell’articolo: Ferrari S, Hars M, Biver E, Uebelhart B, Joly AC, Herrmann F, Meier C, Lippuner K. Preventing post-denosumab bone loss with zoledronate: a 2-year randomized trial in post-menopausal women without and with pre-exposure to bisphosphonates....
